|
CCDC88A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92080000005479E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27409999999928E-05 |
| Normal-vs-Stage2 |
7.62619999999936E-05 |
| Normal-vs-Stage3 |
3.439200E-04 |
| Normal-vs-Stage4 |
1.03860000000289E-06 |
| Stage1-vs-Stage2 |
4.404600E-01 |
| Stage1-vs-Stage3 |
7.976200E-01 |
| Stage1-vs-Stage4 |
6.890100E-02 |
| Stage2-vs-Stage3 |
6.390800E-01 |
| Stage2-vs-Stage4 |
3.938000E-01 |
| Stage3-vs-Stage4 |
1.867410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71595999999274E-05 |
| Normal-vs-AfricanAmerican |
1.298380E-03 |
| Normal-vs-Asian |
2.355700E-04 |
| Caucasian-vs-AfricanAmerican |
7.412000E-01 |
| Caucasian-vs-Asian |
6.339600E-01 |
| AfricanAmerican-vs-Asian |
9.778000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.243910E-03 |
| Normal-vs-Female |
2.78090000027653E-07 |
| Male-vs-Female |
2.885800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.048800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.22570000102596E-08 |
| Normal-vs-Age(61-80Yrs) |
4.215100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.544800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.639900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.116800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.045620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.373400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.590200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.113160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.142600E-01 |
| Classical-VS-Follicular |
4.184400E-01 |
| Classical-VS-Other |
3.339000E-01 |
| Classical-VS-Normal |
2.47069999999017E-05 |
| Tall-VS-Follicular |
9.295000E-01 |
| Tall-VS-Other |
6.323600E-01 |
| Tall-VS-Normal |
3.219800E-03 |
| Follicular-VS-Other |
5.212000E-01 |
| Follicular-VS-Normal |
7.96830000000526E-05 |
| Other-VS-Normal |
8.438900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79300000016747E-07 |
| Normal-vs-N1 |
9.93000000004685E-07 |
| N0-vs-N1 |
3.496400E-01 |
|
|
